ER
Elizabeth E Reed (SVP, GC & CORPORATE SECRETARY) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.2M of TVTX (35,800 sh across 2 lots, as filed), executed Sep 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.7M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$250K10,000 sh × $25.00
Exec Sep 22 2025
Filed Sep 24 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $104K
4,920 sh × $21.05
Exec May 5 2025
Filed May 5 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $188K
8,000 sh × $23.53
Exec Feb 12 2025
Filed Feb 12 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $177K
8,951 sh × $19.78
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET